StockNews.AI
EVGN
StockNews.AI
3 hrs

Evogene Schedules Third Quarter 2025 Financial Results Release

1. Evogene will release Q3 2025 financial results on November 20. 2. A conference call is scheduled for the same day to discuss results. 3. Evogene specializes in generative chemistry for pharmaceuticals and agriculture. 4. Their AI platform improves drug design efficiency and reduces costs. 5. Focus on real-world innovation driven by scientific advancement.

3m saved
Insight
Article

FAQ

Why Bullish?

Positive live engagement indicates confidence and potential for growth, similar to past earnings results boosts.

How important is it?

The scheduled earnings call showcases company transparency and potential growth, appealing to investors.

Why Short Term?

Upcoming results can quickly impact stock price, as seen in past earnings reports.

Related Companies

VRTXNVSMRNA
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET , /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the third quarter of 2025, on Thursday, November 20, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conference, please register in advance: https://www.veidan-conferencing.com/evogene The entire conference will be available online on the company's website a few days after. About Evogene: Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation". Learn more at: www.evogene.com. Logo: https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg Contact: [email protected] +972-8-9311901 SOURCE Evogene

Related News